WASHINGTON--(BUSINESS WIRE)--Today, Xlear is filing a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA). The Pre-EUA is a first step in seeking ...
NEWPORT, Ky., Aug. 10, 2020 /PRNewswire/ -- Ethos Laboratories announced today that the company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its ...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced that it has ...